This study extends our knowledge about the regulation of proline synthesis and tumor progression by transcription factor and its derived lncRNA, and suggests that MZF1‐AS1/PARP1/E2F1 axis may be a therapeutic target for tumors. The gene discussed is PARP1; the disease is neoplasm.